Panel Discussion: Accelerated Approval, Small Patient Populations & Precision Medicine: Executing Clinical Trials in Rare Kidney Diseases

Time: 9:00 am
day: Day Two


• Clarifying heterogeneous disease pathogenesis to investigate exciting targets
• Analyzing the landscape for early and disease specific biomarkers to monitor disease progression
• Navigating patient enrolment in the context of exploding competition for patients with specific disease criteria